Source link : https://newshealth.biz/health-news/paclitaxel-matches-cisplatin-hipec-in-ovarian-cancer/

TOPLINE: Patients with advanced ovarian cancer undergoing interval cytoreductive surgery who received paclitaxel-based hyperthermic intraperitoneal chemotherapy (HIPEC) during surgery appeared to have comparable overall survival and disease-free survival rates to those who received cisplatin-based HIPEC. METHODOLOGY: Although the use of HIPEC remains controversial, cisplatin-based HIPEC during cytoreductive surgery may benefit patients with advanced ovarian cancer; […]

The post Paclitaxel Matches Cisplatin HIPEC in Ovarian Cancer first appeared on News Health.

—-

Author : News Health

Publish date : 2025-07-07 08:51:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678